| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7291132 | LILLY | Medication dispensing apparatus with triple screw threads for mechanical advantage |
Aug, 2024
(2 months from now) | |
Humulin 70/30 is owned by Lilly.
Humulin 70/30 contains Insulin Recombinant Human; Insulin Susp Isophane Recombinant Human.
Humulin 70/30 has a total of 1 drug patent out of which 0 drug patents have expired.
Humulin 70/30 was authorised for market use on 25 April, 1989.
Humulin 70/30 is available in injectable;injection dosage forms.
The generics of Humulin 70/30 are possible to be released after 09 August, 2024.
Market Authorisation Date: 25 April, 1989
Treatment: NA
Dosage: INJECTABLE;INJECTION
More Information on Dosage
HUMULIN 70/30 family patents
